Pet nutrition tablets

Pet chewable tablets OEM and tablet contract manufacturing, with defined nutrient amounts, handling and packaging requirements.

Discuss your project
Chewable tablets and defined nutrient amounts

Chewable tablets and defined nutrient amounts

Tablets allow a brand to define a counted daily serving. Discuss the intended animal size and whether the product is offered whole or with another approved feeding method. Ingredient amounts, tablet dimensions and handling should be considered together before the bottle count is fixed.

Multivitamin, mineral and joint nutrition tablets can be discussed for a defined species and life stage. The brief should separate tablet weight from active ingredient content and state whether the tablet will be offered whole, broken or mixed with food. Any break line and serving instruction need a suitable finished product.

Pet chewable tablets OEM and tablet contract manufacturing need targets for unit mass, nutrient declarations, hardness and any permitted subdivision. Discuss multivitamin and B-complex directions using the amounts contributed by the intended daily serving. Joint nutrition blends may include proposed glucosamine, chondroitin or MSM specifications, subject to formulation and market review.

SAM-e and botanical tablet enquiries

The development brief should cover tablet weight and dimensions, relevant ingredient content, physical integrity, serving instructions, bottle count and closure. Agree which characteristics will be checked at release and which require additional study.

For a SAM-e liver-support tablet concept, provide the ingredient form, assay and intended declaration. Liver and gallbladder, urinary, heart or respiratory nutrition descriptions require careful claim review and species assessment. A tablet supplied for nutrition must not be presented as treatment for nerve pain, cough or disease. Stability and packaging requirements follow the actual formula.

Packaging and project terms

The final formulation, species directions, pack configuration and commercial minimum are confirmed after review. Catalogue examples are development references and do not establish a market authorisation.

Documentation for review

Product specifications and a COA can be provided. Third-party heavy metal, microbiological and mycotoxin testing can be arranged with the scope, laboratory, cost and timing agreed for the project. Send the target species, market and intended serving with your enquiry.

Product & packaging references

Explore product development directions from our catalogue. Each reference can be discussed as an OEM/ODM project for the intended species and sales market.

Explore the catalogue range

Catalogue specification references

  • Pack sizes: 120 / 150 / 200 tablets
  • Unit weights: 0.2 / 0.3 / 0.5 / 1 g
  • Packaging: Bottles

Images show digitally rebranded product and packaging references. Formula, ingredient suitability, sourcing, pack size and final label are confirmed for each project. These images are not a certificate, approved final label or evidence of a tested finished formula.

Questions for your product brief

What should a pet B-complex or multivitamin brief specify?

List each vitamin form and the proposed declaration per daily serving. Include the intended species, life stage and base diet so the total intake can be assessed. A full B-complex label does not establish that every animal needs an added multivitamin or that a higher declared amount is appropriate.

How should glucosamine, chondroitin and MSM amounts be compared?

Specify the ingredient forms and the amount contributed by the intended daily serving, including how any declared active content will be measured. Keep the full recipe and species in the comparison. A dog hip and joint soft-chew concept needs review of the finished formula; combining ingredient names does not establish treatment of joint disease.

What is needed for a SAM-e liver and gallbladder nutrition concept?

State the ingredient form, assay, proposed daily contribution and intended species. Review any botanical blend, packaging and stability requirements with the actual formula. Liver and gallbladder support is a development direction here; it does not establish disease treatment, medicine compatibility or suitability for an animal with an existing condition.

Can a B-vitamin or herbal product claim nerve-pain relief?

We do not position B-complex vitamins or herbal nutrition blends as treatment for nerve pain. The proposed nutrient forms, amounts, species and daily serving can be reviewed as a nutrition brief. Pain and suspected neurological problems require veterinary assessment; a supplement catalogue cannot establish diagnosis or a treatment plan.

Can active-ingredient amounts be adjusted to a buyer specification?

Provide the exact ingredient forms and target declarations per unit and per daily serving. Feasibility depends on the whole formulation, format, species and destination. A change may require different unit dimensions, repeat testing and revised instructions. An initial adjustment request does not establish an approved formula or a confirmed production price.

Product references are starting points for discussion. Formula, suitability, evidence, packaging and commercial conditions are confirmed for the project.

What are you planning to make?

Tell us your target species, nutrition direction, format and sales market. We will help define the next technical and commercial questions.

Discuss your project